Our Services
Medical Information
Helpful Resources
Published on: 2/11/2026
Naltrexone can reduce alcohol cravings and prevent relapse at standard doses, and at low doses it is used off label to potentially ease chronic pain, autoimmune inflammation, and some perimenopausal symptoms in women, though benefits vary. There are several factors to consider, including liver risks, precipitated opioid withdrawal, pregnancy and breastfeeding, proper testing, and close follow up with your clinician; for the specific next steps and important details that could change your plan, see the complete guidance below.
Naltrexone is a medication that has been used for decades to treat opioid and alcohol dependence. In recent years, it has also gained attention—especially at lower doses—for its potential role in managing certain chronic conditions that affect women.
If you're wondering whether naltrexone could help you, this guide explains what it does, how it may benefit women, possible side effects, and what steps to take next.
Naltrexone is a prescription medication that blocks opioid receptors in the brain. In standard doses (50 mg or higher), it's approved by the FDA to:
At much lower doses (commonly called low-dose naltrexone or LDN, typically 1–4.5 mg), doctors sometimes prescribe it off-label for conditions involving chronic pain, inflammation, or immune dysfunction.
"Off-label" means the medication is FDA-approved for one purpose but prescribed for another based on emerging research and clinical experience.
Naltrexone works differently depending on the dose.
At low doses, naltrexone appears to:
This immune-modulating effect is why some healthcare providers consider LDN for autoimmune or inflammatory conditions more common in women.
While research is ongoing, naltrexone—especially low-dose naltrexone—has been explored in several areas relevant to women's health.
Some women with chronic pain conditions may benefit from LDN, including:
Small studies suggest LDN may reduce pain sensitivity by calming overactive immune responses in the nervous system.
Women are more likely than men to develop autoimmune diseases. LDN has been studied (though not yet widely FDA-approved for these uses) in:
Some patients report improved energy and fewer flares, but larger studies are still needed.
Women may respond differently than men to alcohol's effects. Standard-dose naltrexone can:
This can be especially important during stressful life stages, including perimenopause.
There is limited but growing discussion around whether low-dose naltrexone may help with:
These symptoms can overlap with autoimmune or inflammatory conditions. If you're experiencing any of these changes and want to understand whether they might be hormone-related, try this free Peri-/Post-Menopausal Symptoms checker to help identify patterns and prepare for a more informed conversation with your healthcare provider.
Depending on the condition being treated, possible benefits may include:
It's important to remember that results vary. Naltrexone is not a cure-all, and it does not work for everyone.
Like all medications, naltrexone can cause side effects. Most are mild and temporary, but some require medical attention.
With low-dose naltrexone, side effects are often milder but may include:
If you are currently taking opioid pain medication, you must not start naltrexone without medical supervision. Doing so can trigger sudden and severe withdrawal symptoms.
If you experience symptoms such as severe abdominal pain, yellowing of the skin or eyes, confusion, chest pain, or difficulty breathing, seek immediate medical attention.
Naltrexone may not be appropriate if you:
Always provide your full medication list to your healthcare provider before starting naltrexone.
Women's bodies process medications differently than men's bodies. Factors that may affect how naltrexone works include:
Additionally, symptoms like fatigue, mood swings, or joint pain may have multiple causes—including thyroid disease, autoimmune conditions, perimenopause, or mental health disorders. Naltrexone addresses specific mechanisms, not all possible causes.
This is why a proper evaluation matters.
If you're considering naltrexone, take these steps:
Write down:
If you're noticing symptoms that could be related to hormonal changes—like hot flashes, mood shifts, or sleep problems—use this Peri-/Post-Menopausal Symptoms assessment tool to help organize what you're experiencing and bring clearer information to your doctor's appointment.
Depending on your situation, your doctor may recommend:
Ask your provider:
Naltrexone should not be a "set it and forget it" medication. Regular follow-up ensures:
Naltrexone is not a quick fix. For alcohol use disorder, it works best when combined with:
For chronic pain or autoimmune conditions, it may take several weeks to notice improvement. Some women feel better within a month; others may need dose adjustments.
If there is no improvement after a reasonable trial period, your doctor may recommend stopping it.
Naltrexone is a well-established medication with proven benefits for alcohol and opioid use disorders. Low-dose naltrexone is an emerging option that may help some women with chronic pain or inflammatory conditions, though research is still evolving.
It can be helpful—but it's not harmless, and it's not appropriate for everyone.
If you are experiencing:
Seek urgent medical care immediately.
For anything that could be serious or life-threatening, speak to a doctor right away.
For non-urgent concerns, schedule a thoughtful discussion with your healthcare provider to determine whether naltrexone fits your specific health profile.
When used appropriately and monitored carefully, naltrexone can be a valuable tool—but the right diagnosis and medical supervision are the foundation of safe, effective treatment.
(References)
* Brown, N., & Stagnaro, D. L. (2021). Low-dose naltrexone for the treatment of chronic pain and fatigue: a review of the literature. *Journal of Pain Research*, *14*, 3283–3293.
* Rakstis, H., & O'Hearn, M. (2022). The use of low-dose naltrexone (LDN) in autoimmune diseases: a narrative review. *Clinical and Experimental Rheumatology*, *40*(6), 1146–1152.
* Patten, D. K., Patel, D. A., Martin, V., Patel, T., & Vorys, B. (2020). Low-dose naltrexone in chronic pain: a systematic review and meta-analysis. *Journal of Pain and Palliative Care Pharmacotherapy*, *34*(4), 297–311.
* Park, E. S., Patel, N. P., Jaber, M. M., Vorys, B., & Doshi, A. A. (2022). Low-dose naltrexone for the treatment of fibromyalgia: a review of the literature. *Journal of Pain and Palliative Care Pharmacotherapy*, *36*(1), 1–9.
* Johnson, A., Bains, S., Van Dyken, J., & Braganza, A. (2024). Low-dose naltrexone for the treatment of myalgic encephalomyelitis/chronic fatigue syndrome: a retrospective chart review. *Journal of Pain and Palliative Care Pharmacotherapy*, *38*(1), 1–8.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.